» Articles » PMID: 31308652

Anticandidal Activity of Biosynthesized Silver Nanoparticles: Effect on Growth, Cell Morphology, and Key Virulence Attributes of Candida Species

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2019 Jul 17
PMID 31308652
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The pathogenicity in Candida spp was attributed by several virulence factors such as production of tissue damaging extracellular enzymes, germ tube formation, hyphal morphogenesis and establishment of drug resistant biofilm. The objective of present study was to investigate the effects of silver nanoparticles (AgNPs) on growth, cell morphology and key virulence attributes of Candida species. AgNPs were synthesized by the using seed extract of (Sc), and were characterized by UV-Vis spectrophotometer, Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), energy-dispersive X-ray (EDX), and transmission electron microscopy (TEM). ScAgNPs were used to evaluate their antifungal and antibacterial activity as well as their potent inhibitory effects on germ tube and biofilm formation and extracellular enzymes viz. phospholipases, proteinases, lipases and hemolysin secreted by spp. The MICs values of ScAgNPs were ranged from 0.125-0.250 mg/ml, whereas the MBCs and MFCs were 0.250 and 0.500 mg/ml, respectively. ScAgNPs significantly inhibit the production of phospholipases by 82.2, 75.7, 78.7, 62.5, and 65.8%; proteinases by 82.0, 72.0, 77.5, 67.0, and 83.7%; lipase by 69.4, 58.8, 60.0, 42.9, and 65.0%; and hemolysin by 62.8, 69.7, 67.2, 73.1, and 70.2% in , , , and , respectively, at 500 μg/ml. ScAgNPs inhibit germ tube formation in C. albicans up to 97.1% at 0.25 mg/ml. LIVE/DEAD staining results showed that ScAgNPs almost completely inhibit biofilm formation in C. albicans. TEM analysis shows that ScAgNPs not only anchored onto the cell surface but also penetrated and accumulated in the cytoplasm that causes severe damage to the cell wall and cytoplasmic membrane. To summarize, the biosynthesized ScAgNPs strongly suppressed the multiplication, germ tube and biofilm formation and most importantly secretion of hydrolytic enzymes (viz. phospholipases, proteinases, lipases and hemolysin) by Candia spp. The present research work open several avenues of further study, such as to explore the molecular mechanism of inhibition of germ tubes and biofilm formation and suppression of production of various hydrolytic enzymes by Candida spp.

Citing Articles

Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts.

Almatroudi A Biology (Basel). 2025; 14(2).

PMID: 40001933 PMC: 11852148. DOI: 10.3390/biology14020165.


Green synthesis of silver nanoparticles from shallot extract for potent antifungal activity enhanced by blue diode laser irradiation against candida albicans.

Sihombing C, Astuti S, Arifianto D, Yaqubi A, Zaidan A, Nurdin D Lasers Med Sci. 2025; 40(1):76.

PMID: 39918643 DOI: 10.1007/s10103-025-04321-1.


Synthesis of Silver Nanoparticles and Evaluation of Antimicrobial Activity Using the Aqueous Extract of Pterodon emarginatus Seeds.

Leal Pereira M, Pereira da Silva A, Magalhaes L, Magalhaes M, Magalhaes T, de Souza Franco E Cureus. 2024; 16(12):e76382.

PMID: 39722661 PMC: 11669398. DOI: 10.7759/cureus.76382.


"Therapeutic advancements in nanomedicine: The multifaceted roles of silver nanoparticles".

Karunakar K, Cheriyan B, R K, M G, B A Biotechnol Notes. 2024; 5:64-79.

PMID: 39416696 PMC: 11446369. DOI: 10.1016/j.biotno.2024.05.002.


The progress and future of the treatment of Candida albicans infections based on nanotechnology.

Gao Y, Cao Q, Xiao Y, Wu Y, Ding L, Huang H J Nanobiotechnology. 2024; 22(1):568.

PMID: 39285480 PMC: 11406819. DOI: 10.1186/s12951-024-02841-6.


References
1.
Ramkumar V, Pugazhendhi A, Gopalakrishnan K, Sivagurunathan P, Saratale G, Bao Dung T . Biofabrication and characterization of silver nanoparticles using aqueous extract of seaweed and its biomedical properties. Biotechnol Rep (Amst). 2017; 14:1-7. PMC: 5397105. DOI: 10.1016/j.btre.2017.02.001. View

2.
Fidel Jr P, Vazquez J, Sobel J . Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999; 12(1):80-96. PMC: 88907. DOI: 10.1128/CMR.12.1.80. View

3.
Saravanan M, Barik S, MubarakAli D, Prakash P, Pugazhendhi A . Synthesis of silver nanoparticles from Bacillus brevis (NCIM 2533) and their antibacterial activity against pathogenic bacteria. Microb Pathog. 2018; 116:221-226. DOI: 10.1016/j.micpath.2018.01.038. View

4.
Modrzewska B, Kurnatowski P . Adherence of Candida sp. to host tissues and cells as one of its pathogenicity features. Ann Parasitol. 2015; 61(1):3-9. View

5.
Mallmann E, Cunha F, Castro B, Maciel A, Menezes E, Fechine P . Antifungal activity of silver nanoparticles obtained by green synthesis. Rev Inst Med Trop Sao Paulo. 2015; 57(2):165-7. PMC: 4435016. DOI: 10.1590/S0036-46652015000200011. View